$12.55
0.060.48%
At close: -
$12.55
0.000.00%
After Hours: Feb 14, 4:00 PM EDT
Comments
Loading...
Bicycle Therapeutics (BCYC) Forecast
NewsEarningsBicycle Therapeutics (BCYC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBicycle Therapeutics (NASDAQ:BCYC) Stock Quotes, Forecast and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ:BCYC) through any online brokerage.
Who are Bicycle Therapeutics (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN) and Cogent Biosciences (NASDAQ:COGT).
What is the forecast, or price target, for Bicycle Therapeutics (BCYC) stock?
Bicycle Therapeutics has a consensus price target of $38.07.
What is the current price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $12.55 last updated February 14, 2025 at 4:00 PM EST.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There are no upcoming dividends for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.